Literature DB >> 16998295

[Inflammatory pseudotumor of liver--a clinical review of 15 cases].

Kyung Sik Park1, Byoung Kuk Jang, Woo Jin Chung, Kwang Bum Cho, Jae Seok Hwang, Yu Na Kang, Koo Jeong Kang, Mi Jeong Kim, Jung Hyeok Kwon.   

Abstract

BACKGROUND/AIMS: Inflammatory pseudotumor rarely occurs in the liver. However, it is important to discriminate it from malignant hepatic tumor in order to avoid unnecessary surgery. We aimed to elucidate the characteristic features of this disease entity by analyzing our experiences and by reviewing the related literatures.
METHODS: Fifteen patients were enrolled during a recent three-year period. The patients were pathologically diagnosed with inflammatory pseudotumor of the liver, and their clinical and imaging findings were analyzed retrospectively.
RESULTS: Our study population was composed of ten men and five women, and their mean age was 60.3+/-9.2 years. Their initial diagnoses were inflammatory pseudotumor (n=8), malignant tumors (n=3) and abscess (n=4). Twelve of 15 patients were associated with biliary diseases such as biliary stone, gallbladder cancer, empyema or cholangiocarcinoma. The most common symptom was abdominal pain. The most common CT and MR findings could be summarized as a delayed hyperattenuating mass with an internal hypoattenuating component. The tumors were solitary in 13 patients and multiple in two patients. The lesions regressed spontaneously in seven patients. Four patients were treated by antibiotics and 3 patients by surgical resection.
CONCLUSIONS: Inflammatory pseudotumor of the liver seems to have relatively common clinical and imaging features, as described above. However, these features are not disease-specific; thus, preoperative histologic confirmation is necessary to avoid unnecessary surgery.

Entities:  

Mesh:

Year:  2006        PMID: 16998295

Source DB:  PubMed          Journal:  Korean J Hepatol        ISSN: 1738-222X


  6 in total

Review 1.  Benign focal liver lesions masquerading as primary liver cancers on MRI.

Authors:  Manickam Subramanian; Hsien Min Low; Myeong-Jin Kim; Cher Heng Tan
Journal:  Diagn Interv Radiol       Date:  2020-05       Impact factor: 2.630

2.  Clinicopathological features and post-resection outcomes of inflammatory pseudotumor of the liver.

Authors:  Kibong Oh; Shin Hwang; Chul-Soo Ahn; Ki-Hun Kim; Deok-Bog Moon; Tae-Yong Ha; Gi-Won Song; Dong-Hwan Jung; Seung-Mo Hong
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2021-02-28

3.  Hepatic inflammatory pseudotumor misinterpreted as hepatocellular carcinoma.

Authors:  Jae Yoon Jeong; Joo Hyun Sohn; Tae Yeob Kim; Woo Kyoung Jeong; Jinoo Kim; Ju Yeon Pyo; Young Ha Oh
Journal:  Clin Mol Hepatol       Date:  2012-06-26

4.  Inflammatory myofibroblastic tumor mimicking hepatocellular carcinoma with dense lipiodol uptake.

Authors:  Seong Woo Hong; Woo Yong Lee; Yeo Goo Chang; Byungmo Lee; Hye Kyung Lee; Ho Kyun Kim
Journal:  J Korean Surg Soc       Date:  2013-07-25

5.  Diagnosis efficacy of CEUS for hepatic inflammatory lesions.

Authors:  Yuanyuan Guo; Xiachuan Qin; Shaoxian Chen; Xuebin Liu; Peng Gu
Journal:  J Clin Lab Anal       Date:  2020-02-03       Impact factor: 2.352

6.  Clinical features, image findings, and prognosis of inflammatory pseudotumor of the liver: a multicenter experience of 45 cases.

Authors:  Jun Young Park; Moon Seok Choi; Young-Suk Lim; Jang Won Park; Seung Up Kim; Yang Won Min; Geum-Youn Gwak; Yong-Han Paik; Joon Hyoek Lee; Kwang Cheol Koh; Seung Woon Paik; Byung Chul Yoo
Journal:  Gut Liver       Date:  2013-11-21       Impact factor: 4.519

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.